sensitized to peanuts. The lowest incidence (1.7%) was observed among children whose mothers consumed peanuts while breastfeeding and directly introduced peanuts before 12 months. Incidence was significantly higher (P < .05) if mothers consumed peanuts while breast-feeding but delayed introducing peanuts to their infant beyond 12 months (15.1%), or if mothers avoided peanuts themselves but directly introduced peanuts by 12 months (17.6%). Interaction analyses controlling for study group and maternal atopy confirmed that maternal peanut consumption while breast-feeding and infant peanut consumption by 12 months were protective in combination, whereas either exposure in isolation was associated with an increased risk of sensitization (P interaction 5 .003). Conclusions: In this secondary analysis, maternal peanut consumption while breast-feeding paired with direct introduction of peanuts in the first year of life was Key words: Breast-feeding, lactation, maternal peanut consumption, peanut allergy, peanut sensitization, timing of peanut introduction
The prevalence of food allergy has increased in recent decades, particularly in the United Kingdom and other industrialized nations. [1] [2] [3] [4] [5] Approximately 7% of Canadian children have a food allergy with peanut being among the most common. 6, 7 There are many theories regarding the cause of food allergy, including breaches in oral tolerance and alternative routes of exposure leading to sensitization. [8] [9] [10] Recently, there has also been speculation that the timing of introduction to specific foods may be associated with the risk of sensitization. [11] [12] [13] [14] Beginning in the 1990s, national pediatric and allergy societies recommended delaying the introduction of common highly allergenic foods, including peanuts, until 2 or 3 years of age. However, alongside these recommendations, the incidence and prevalence of food allergy continued to rise over the following decade, 15 casting doubt on delayed introduction as an effective strategy for allergy prevention. Recent studies suggest that early introduction to peanuts may in fact reduce the likelihood of developing peanut allergy. 11, 16 In the Learning Early About Peanut allergy (LEAP) study, a randomized controlled trial in high-risk infants, early introduction of peanuts (between 4 and 11 months) significantly decreased the development of peanut allergy by 5 years of age. 16 Similarly, in the randomized Enquiring About Tolerance (EAT) trial of early introduction to allergenic foods, 17 there was a significantly lower prevalence of peanut allergy among children adhering to the early introduction protocol, although differences were not significant in the intention-to-treat analysis. While infant feeding guidelines are already being revised in light of these new findings, 18 there are no data definitively showing risk or benefit from maternal peanut consumption while breast-feeding. Although not addressed in the LEAP and EAT trials, it is known that oral peanut exposure can occur through breast milk, 19, 20 and this indirect exposure could potentially influence peanut sensitization.
In 1994, we initiated the randomized Canadian Asthma Primary Prevention Study (CAPPS). 21, 22 One component of our multifaceted intervention was a recommendation to delay peanut introduction until at least 12 months of age, in accordance with the American Academy of Pediatrics guidelines at the time. 23 We subsequently found a trend toward increased incidence of peanut sensitization in the intervention group, 21 although we did not evaluate the specific effects of maternal and infant peanut consumption because food allergy was not a primary focus of the CAPPS trial, where atopic sensitization was primarily measured for the purpose of classifying asthma phenotypes.
Motivated by the current debate and shifting recommendations regarding early introduction of allergenic foods, we took advantage of the unique CAPPS dataset to assess the relationship between maternal consumption of peanut while breast-feeding, timing of direct oral peanut introduction, and sensitization to peanuts at 7 years of age.
METHODS

Study design and population
We performed a secondary analysis of nested cohort data from CAPPS, which has been described in previous reports. 21, 22 Briefly, 545 pregnant women were recruited in 1994 and 1995 from 2 major Canadian cities (Winnipeg and Vancouver). All children had an immediate family history of asthma or 2 first-degree relatives with IgE-mediated allergic disease. Women were randomized to a multifaceted intervention group, or to a control group receiving the usual care recommended by their physicians. Mothers in the control group received no specific instructions about dietary avoidance for themselves or their infant and were advised to follow recommendations from their primary care physician. Mothers in the intervention group were asked to avoid peanuts, nuts, fish, and eggs during their pregnancy and while breast-feeding. They were encouraged to breast-feed for at least 4 months and up to 12 months if possible. They were also advised to avoid introducing solid foods to their infants until after 6 months of age and to delay the introduction of allergenic foods (eg, milk, eggs, seafood, and peanuts) until at least 12 months. Compliance was monitored through frequent questionnaires documenting maternal and infant diet. Peanut sensitization was measured by skin prick testing at 7 years of age. In the current secondary analysis, we applied a nested cohort approach and specifically evaluated the association of maternal and infant peanut consumption with peanut sensitization, regardless of assigned study group. Statistical models were adjusted for study group to account for the randomized study design and other elements of the multifaceted intervention. Ethics committees at the University of British Columbia and the University of Manitoba approved the study, and participants provided written consent.
Main exposure: maternal and infant peanut consumption
The timing of peanut introduction was obtained from dietary questionnaires completed at 2 weeks and 4, 8, 12, 18, and 24 months of age. At each time point, mothers completed a table summarizing the consumption of specific foods, including peanuts, and any adverse reactions to these foods. This table included a row labeled ''Age Introduced (months).'' We determined the timing of peanut introduction from the earliest report of peanut introduction in the series of diet questionnaires. Mothers also reported on breast-feeding (''Are you breast-feeding?'') and their own peanut intake (''During the past week have you had peanuts?'') at each time point; these data were combined to estimate exposure to peanuts through breast milk. Mothers who responded ''Yes'' to both questions on any single questionnaire were considered to have consumed peanuts while breast-feeding.
Main outcome: peanut sensitization at age 7 years Peanut sensitization was assessed by skin prick testing. Children were assessed by a pediatric allergist blinded to the group allocation and questionnaire results. Testing was performed via the prick Lancetter method (Bayer Inc, Mississauga, Ontario) and included common environmental and food (milk, egg, soy, and peanut) allergens, along with a positive (histamine) and negative (saline) controls. A mean wheal diameter of 3 mm or greater than what was elicited by the negative control was considered positive.
Abbreviations used aOR: Adjusted odds ratio CAPPS: Canadian Asthma Primary Prevention Study
EAT: Enquiring About Tolerance LEAP: Learning Early About Peanut allergy OR: Odds ratio
Statistical analysis
For the current study, we excluded children with incomplete data for maternal or infant peanut consumption from birth through 24 months (n 5 29), children who were never breast-fed (n 5 24), and children who were lost to follow-up and not assessed at age 7 years (n 5 150), leaving 342 of the original 545 enrolled children (62.7%) for analysis. These children did not differ systematically from the full cohort with respect to baseline demographic variables or maternal and infant peanut consumption (Table I) . Bivariate screening of potential confounders was performed using chi-squared tests and t tests for categorical and continuous variables, respectively. Logistic regression was used to assess the relationships among maternal peanut consumption while breast-feeding, infant peanut consumption, and peanut sensitization at age 7, controlling for potential confounders. Results are presented as crude odds ratios (OR) and adjusted ORs (aOR) with 95% CI. To address the hypothesized interaction between maternal and infant peanut consumption, an interaction term was tested in the logistic regression model and ORs for each individual exposure (maternal or infant peanut consumption) were estimated while specifying the presence or absence of the other exposure. In addition, a 4-category variable was generated to classify children according to the 4 possible combinations of maternal peanut consumption while breast-feeding and introduction of peanuts to the infant before 12 months (1/1, 1/-, -/1, -/-). This 4-category variable was used in a logistic regression model to estimate the aOR for peanut sensitization relative to children whose mothers consumed peanuts while breast-feeding and introduced peanuts to their infants before 12 months (ie, the double exposed ''1/1'' group). Statistical analysis was performed with SAS 9.4 (SAS Inc, Cary, NC).
RESULTS
Overall, only 77 of 342 families (23%) introduced peanuts to their infant by 12 months; 136 (40%) introduced peanuts between 13 and 24 months and 129 (38%) did not introduce peanuts before 24 months (Table II) . Almost no families (<1%) introduced peanuts before 6 months of age. However, more than half of mothers (58%) reported consuming peanuts while breastfeeding. Mothers who avoided peanuts while breast-feeding were more likely to delay introducing peanuts to their infants (only 14% of peanut-avoiding mothers introduced peanuts before 12 months, compared with 30% of mothers who consumed peanuts while breast-feeding; P < .001). The majority of families in both study groups delayed peanut introduction beyond 12 months, as was the standard at the time; however, delayed introduction was significantly more likely and nearly universal in the intervention group (95%) compared to the control group (58%) (P < .0001) (Table II) . Mothers in the intervention group were also significantly more likely to avoid peanuts while breast-feeding compared to mothers in the control group (55.8% vs 26.1%, P < .001) (Table II) , despite breast-feeding significantly longer (median 8.7 vs 6.5 months; P 5 .01). There was no difference in maternal or infant peanut consumption according to study site, maternal education, infant birth order, or maternal food allergy (see Table E1 in this article's Online Repository at www.jacionline.org).
By 7 years of age, 32 of 342 children (9.4%) were sensitized to peanuts. The incidence of peanut sensitization was not significantly different between study groups, although we observed a trend toward higher rates in the intervention (n 5 21 of 181, 11.6%) versus the control group (n 5 11 of 161, 6.8%) (P 5 .13) ( Table II) . Independent of study group and maternal atopy, maternal and infant peanut consumption were significantly associated with peanut sensitization at 7 years of age (Fig 1) . The lowest incidence of peanut sensitization (1.7%) was observed when mothers consumed peanuts while breast-feeding and introduced peanuts to their infant's diet before 12 months. Compared with this group, the incidence of peanut sensitization was significantly higher (17.6%; P < .05) when mothers introduced peanuts to their infants before 12 months, but did not consume peanuts themselves while breast-feeding (aOR: 12.45, 95% CI: 1.18-131.30, adjusted for study group and maternal atopy). Peanut sensitization was also significantly higher (15.6%; P < .05) when mothers consumed peanuts while breast-feeding, but delayed introducing peanuts directly to their infant's diet until after 12 months (aOR: 8.30, 95% CI: 1.05-65.80). A formal interaction analysis confirmed that maternal peanut consumption while breast-feeding and direct introduction of peanut by 12 months were protective in combination, whereas either exposure in isolation was associated with an increased risk of peanut sensitization (P interaction 5 .003) (Table III) .
DISCUSSION
This nested cohort study provides evidence that both the timing and route of peanut introduction may be associated with peanut sensitization. In our secondary analysis of the 1995 CAPPS study, we have identified a potentially novel interaction between maternal and infant peanut consumption, where early direct peanut introduction (before 12 months) was associated with protection against sensitization only if mothers consumed peanuts while breast-feeding, and maternal peanut consumption during lactation was associated with an increased risk of peanut sensitization only if direct peanut introduction was delayed beyond 12 months. In our study population, the incidence of peanut sensitization by school age was substantially lower (1.7%) when mothers reported consuming peanuts while breast-feeding and introducing peanut directly to their infants in the first year of life, compared with any other combination of maternal and infant peanut consumption (6% to 18% sensitization). Moreover, our current results help to explain the previously reported trend toward increased peanut sensitization in the intervention arm of the CAPPS trial, 21 suggesting this was likely due to maternal and infant peanut avoidance.
Our findings add to a growing body of evidence from observational studies [24] [25] [26] and randomized trials 16, 17, 27 showing that delaying the introduction of allergenic foods may increase the risk of allergy or sensitization. After observing a strong inverse association between peanut consumption in infancy and peanut allergy in childhood, 11 Du Toit et al 16 conducted the randomized LEAP trial, which has confirmed that early introduction of peanut (between 4 and 11 months) decreases the risk of peanut allergy in high-risk children. Our current secondary analysis uniquely examined the potential role of maternal peanut consumption, which was not addressed in the LEAP trial, although we lacked information on the dose and frequency of maternal peanut intake, which limited our ability to quantify this exposure.
While not all studies find an association between maternal peanut consumption and peanut allergy in offspring, 8, 28 some have found that mothers of children with peanut allergy are more likely to report consuming peanuts while pregnant or breast-feeding compared to mothers of children who do not have peanut allergy. 29 However, these retrospective studies are subject to recall bias because maternal diet was reported years later, after the child's allergy diagnosis. Recall bias was minimized in our study by repeatedly collecting maternal and infant dietary information during infancy, prior to the measurement of peanut sensitization at school age. Moreover, previous studies have not evaluated the potential interaction between maternal and infant peanut consumption. The associations noted in our secondary analysis suggest that maternal peanut consumption while breast-feeding may differentially influence peanut sensitization depending on the timing of direct peanut introduction, and vice versa, although further research is needed to formally test this hypothesis.
The lowest incidence of peanut sensitization in our study population was observed when both mother and infant consumed peanuts. Further research is warranted to determine whether this potential interaction extends to peanut allergy and applies equally in other settings and populations. While the LEAP trail focused on early peanut introduction without explicitly addressing maternal consumption, we suspect that most mothers randomized to early peanut introduction likely also consumed peanuts themselves, resulting in frequent ''double exposure'' among breast-fed infants in the intervention group. Given our current results, we recommend that peanut exposure through breast-feeding be considered in future research examining the timing of peanut introduction.
Although the underlying mechanisms require further investigation, our findings suggest that both maternal and infant peanut consumption may help prevent sensitization. When transmitted through breast-feeding, peanut antigens are delivered to the infant along with a plethora of bioactive factors including maternal immunoglobulins, cytokines, microbiota, and immune cells. 30 Packaged with these immunomodulatory factors, peanut antigens in breast milk may prime the infant immune system to develop tolerance when peanut is directly consumed a few months later. On the other hand, we speculate that exposure to peanut antigens in breast milk without peanut consumption during infancy may facilitate sensitization.
Strengths of this nested cohort study include the longitudinal follow-up from pregnancy through early childhood and frequent reporting of maternal and infant diet throughout infancy, which minimizes the risk of recall bias. This study also has important limitations, including incomplete dietary information and loss to follow-up, although no systematic differences were observed between children with and without complete data. The sample sizes were relatively small for some exposure groups, which reduced the precision of our effect estimates. While it would be ideal to evaluate narrower time windows of peanut introduction in the first year of life, this was not possible in our study because very few infants consumed peanuts before 10 months. We studied children considered to be at high genetic risk for allergic disease, thus our findings may not apply to the general population. Although peanut sensitization was objectively measured, we could not evaluate peanut allergy, as oral food challenges were not performed. While the timing of direct peanut introduction was specifically captured in our study, maternal peanut consumption Values are n (%). N 5 342 breast-fed infants with complete data for maternal and infant peanut consumption, and child peanut sensitization at age 7. Comparisons by chi-squared test. Sensitization by skin prick test (mean wheal > _3 mm).
while breast-feeding was not explicitly reported, and our estimate based on combined data for current breast-feeding and recent peanut consumption may have resulted in some exposure misclassification. Finally, we did not capture environmental peanut exposure or maternal peanut consumption during pregnancy, and we did not document the frequency or amount of maternal and infant peanut consumption. As a result, we could not address the relative importance of environmental and in utero exposure or regular versus infrequent peanut consumption.
It is also important to note that CAPPS was originally designed and implemented as a multifaceted intervention trial, which adds a layer of complexity to the current nested cohort analysis. CAPPS was powered for asthma as the primary outcome; therefore, we may have been underpowered to detect differences in peanut sensitization between study groups, although this was not the primary goal of our current secondary analysis, which focused on associations between early peanut exposure and later peanut sensitization. We have adjusted for possible confounding by study group; however, residual confounding due to treatment contamination cannot be ruled out.
In summary, we found that introduction of peanut before 12 months of age was associated with a reduced risk of peanut sensitization by school age, particularly among children whose mothers consumed peanuts while breast-feeding. These results add to emerging evidence that early peanut consumption during infancy can reduce the risk of peanut sensitization later in childhood 16, 17 and suggest this risk could be further reduced in breastfed infants by encouraging maternal consumption of peanuts during lactation. However, our secondary analysis has important limitations related to the study design, population, exposure, and outcome measurements. Thus, before drawing definitive conclusions or changing recommendations, further studies will be required to replicate our findings in other settings and contemporary populations, which have significantly different peanut consumption patterns compared to those of the 1995 CAPPS cohort. In addition, adequately powered and appropriately designed intervention trials will be required to establish whether the associations we have observed are causal and extend to peanut allergy, and to determine the optimal timing and combination of maternal and infant peanut consumption. Research is also needed to explore alternative strategies for mothers with peanut allergy and nonbreast-fed infants. Ultimately, in addition to determining the optimal timing for direct peanut introduction to infants, it will be important to consider breast-feeding and maternal peanut consumption as potential factors contributing to the development and prevention of peanut sensitization. Peanut sensitization at age 7 years according to maternal and infant peanut consumption in the CAPPS cohort. Maternal and infant peanut consumption and breast-feeding were reported at age 2 weeks and 2, 4, 6, 8, 12, and 24 months. Peanut sensitization (> _3 mm mean wheal diameter) was measured by skin prick testing at age 7 years. **ORs from logistic regression adjusting for study group and maternal atopy, using a 4-category variable to classify maternal and infant peanut consumption. P value for interaction between maternal and infant peanut consumption 5 .003. N 5 339 breast-fed infants with complete data on maternal and infant peanut consumption, maternal atopy, and child peanut sensitization at age 7. *Mutually adjusted for maternal and infant peanut consumption, maternal atopy, and study group. The logistic regression model included an interaction term for maternal and infant peanut consumption; odds ratios for each individual exposure (maternal and infant peanut consumption) were estimated in this model while specifying the presence or absence of the other exposure.
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Key messages
d In a high-risk birth cohort of breast-fed children, we provide evidence of an association between peanut introduction in the first year of life and a reduced risk of peanut sensitization by 7 years of age, but only if the mother consumed peanuts while breast-feeding.
d Our data suggest both passive peanut exposure through breast milk and peanut introduction in the first year of life may decrease the risk of peanut sensitization at age 7. Comparisons by chi-squared test. N 5 342 breast-fed infants with complete data for maternal and infant peanut consumption and child peanut sensitization at age 7.
